Karl Herholz1. 1. Wolfson Molecular Imaging Centre, Clinical Neuroscience, University of Manchester, 27 Palatine Road, Manchester, UK. karl.herholz@manchester.ac.uk
Abstract
PURPOSE: Impairment of cholinergic neurotransmission is a well-established fact in Alzheimer's disease (AD), but there is controversy about its relevance at the early stages of the disease and in mild cognitive impairment (MCI). METHODS: In vivo positron emission tomography imaging of cortical acetylcholine esterase (AChE) activity as a marker of cholinergic innervation that is expressed by cholinergic axons and cholinoceptive neurons has demonstrated a reduction of this enzyme activity in manifest AD. The technique is also useful to measure the inhibition of cerebral AChE induced by cholinesterase inhibitors for treatment of dementia symptoms. RESULTS: A reduction of cortical AchE activity was found consistently in all studies of AD and in few cases of MCI who later concerted to AD. CONCLUSION: The in vivo findings in MCI and very mild AD are still preliminary, and studies seem to suggest that cholinergic innervation and AChE as the main degrading enzyme are both reduced, which might result in partial compensation of their effect.
PURPOSE: Impairment of cholinergic neurotransmission is a well-established fact in Alzheimer's disease (AD), but there is controversy about its relevance at the early stages of the disease and in mild cognitive impairment (MCI). METHODS: In vivo positron emission tomography imaging of cortical acetylcholine esterase (AChE) activity as a marker of cholinergic innervation that is expressed by cholinergic axons and cholinoceptive neurons has demonstrated a reduction of this enzyme activity in manifest AD. The technique is also useful to measure the inhibition of cerebral AChE induced by cholinesterase inhibitors for treatment of dementia symptoms. RESULTS: A reduction of cortical AchE activity was found consistently in all studies of AD and in few cases of MCI who later concerted to AD. CONCLUSION: The in vivo findings in MCI and very mild AD are still preliminary, and studies seem to suggest that cholinergic innervation and AChE as the main degrading enzyme are both reduced, which might result in partial compensation of their effect.
Authors: J O Rinne; V Kaasinen; T Järvenpää; K Någren; A Roivainen; M Yu; V Oikonen; T Kurki Journal: J Neurol Neurosurg Psychiatry Date: 2003-01 Impact factor: 10.154
Authors: Valtteri Kaasinen; Kjell Någren; Tarja Järvenpää; Anne Roivainen; Meixiang Yu; Vesa Oikonen; Timo Kurki; Juha O Rinne Journal: J Clin Psychopharmacol Date: 2002-12 Impact factor: 3.153
Authors: S Nagatsuka Si; K Fukushi; H Shinotoh; H Namba; M Iyo; N Tanaka; A Aotsuka; T Ota; S Tanada; T Irie Journal: J Cereb Blood Flow Metab Date: 2001-11 Impact factor: 6.200
Authors: Steven T DeKosky; Milos D Ikonomovic; Scot D Styren; Laurel Beckett; Stephen Wisniewski; David A Bennett; Elizabeth J Cochran; Jeffrey H Kordower; Elliott J Mufson Journal: Ann Neurol Date: 2002-02 Impact factor: 10.422
Authors: Nicolaas I Bohnen; Daniel I Kaufer; Larry S Ivanco; Brian Lopresti; Robert A Koeppe; James G Davis; Chester A Mathis; Robert Y Moore; Steven T DeKosky Journal: Arch Neurol Date: 2003-12
Authors: B Bencherif; C J Endres; J L Musachio; A Villalobos; J Hilton; U Scheffel; R F Dannals; S Williams; J J Frost Journal: Synapse Date: 2002-07 Impact factor: 2.562
Authors: María-Letizia Campanari; María-Salud García-Ayllón; Lidia Blazquez-Llorca; Wilson K W Luk; Karl Tsim; Javier Sáez-Valero Journal: J Mol Neurosci Date: 2013-12-07 Impact factor: 3.444
Authors: David Olivares; Varun K Deshpande; Ying Shi; Debomoy K Lahiri; Nigel H Greig; Jack T Rogers; Xudong Huang Journal: Curr Alzheimer Res Date: 2012-07 Impact factor: 3.498
Authors: Frank Jessen; Hanna Kaduszkiewicz; Moritz Daerr; Horst Bickel; Michael Pentzek; Steffi Riedel-Heller; Michael Wagner; Siegfried Weyerer; Birgitt Wiese; Hendrik van den Bussche; Karl Broich; Wolfgang Maier Journal: Eur Arch Psychiatry Clin Neurosci Date: 2010-10-20 Impact factor: 5.270
Authors: Han Soo Yoo; Seun Jeon; Enrica Cavedo; MinJin Ko; Mijin Yun; Phil Hyu Lee; Young H Sohn; Michel J Grothe; Stefan Teipel; Harald Hampel; Alan C Evans; Byoung Seok Ye Journal: Neurology Date: 2021-12-30 Impact factor: 9.910